Gilead Sciences (GILD) Reports non-Inferiority of Tablet Regimen to Atripla in Phase 3

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. BILL
5. ADI
6. MRK
7. MRNA
8. TJX
9. DE
10. LOW

Go back to Gilead Sciences (GILD) Reports non-Inferiority of Tablet Regimen to Atripla in Phase 3
Gilead Sciences (NASDAQ: GILD) Delayed: 145.84 -1.76 (1.19%)
Previous Close $147.60    52 Week High $108.63 
Open $146.69    52 Week Low $71.39 
Day High $146.82    P/E 80.57 
Day Low $143.76    EPS $1.81 
Volume 1,293,004